Shimoda, A., Murai, K., Hikita, H., Minami, S., Miyake, T., Kuriki, S., Sometani, E., Sung, J., Shigeno, S., Higuchi, Y., Maesaka, K., Shirai, K., Tahata, Y., Saito, Y., Kodama, T., Takahashi, T., Suemizu, H., Takehara, T. (2026). Auranofin, identified by FDA-approved drug library screening, inhibits HBs antigen secretion via lysosomal damage. PLoS ONE. https://doi.org/10.1371/journal.pone.0340023